The Development of a Fluorescence in Situ Hybridization Assay for the Detection of Dysplasia and Adenocarcinoma in Barrett's Esophagus

This publication has 39 references indexed in Scilit:

• Chromosomal gains and genomic loss of p53 and p16 genes in Barrett's esophagus detected by fluorescence in situ hybridization of cytology specimens
  Laboratory Investigation, 2004
• Multitarget Fluorescence In Situ Hybridization Assay Detects Transitional Cell Carcinoma in the Majority of Patients with Bladder Cancer and Atypical or Negative Urine Cytology
  Journal of Urology, 2003
• Chromosome 4 hyperploidy represents an early genetic aberration in premalignant Barrett's oesophagus
  Gut, 2003
• Barrett's adenocarcinomas resemble adenocarcinomas of the gastric cardia in terms of chromosomal copy number changes, but relate to squamous cell carcinomas of the distal oesophagus with respect to the presence of high-level amplifications
  The Journal of Pathology, 2003
• Multiprobe FISH for Enhanced Detection of Bladder Cancer in Voided Urine Specimens and Bladder Washings
  American Journal of Clinical Pathology, 2001
• The Development of a Multitarget, Multicolor Fluorescence in Situ Hybridization Assay for the Detection of Urothelial Carcinoma in Urine
  The Journal of Molecular Diagnostics, 2000
• Chromosomal Imbalances in Barrett's Adenocarcinoma and the Metaplasia-Dysplasia-Carcinoma Sequence
  The American Journal of Pathology, 2000
• Surveillance of patients with Barrett's esophagus for dysplasia and cancer with balloon cytology
  Gastroenterology, 1997
• Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus.
  Gut, 1996
• The Incidence of Adenocarcinoma in Columnar-Lined (Barrett's) Esophagus
  New England Journal of Medicine, 1985